| BHYSX | JMADX | BHYSX / JMADX | |
| Total Expense Ratio | 0.91 | 0.00 | - |
| Annual Report Gross Expense Ratio | 0.93 | 0.78 | 119% |
| Fund Existence | 28 years | 7 years | - |
| Gain YTD | 2.026 | 2.195 | 92% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 27.7B | 198M | 13,990% |
| Annual Yield % from dividends | 6.42 | 6.95 | 92% |
| Returns for 1 year | 5.24 | 5.35 | 98% |
| Returns for 3 years | 28.56 | 29.23 | 98% |
| Returns for 5 years | 23.12 | 18.98 | 122% |
| Returns for 10 years | 65.36 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GUSH | 45.55 | 1.07 | +2.41% |
| Direxion Dly S&P Oil&Gs Ex&Prd Bl 2X ETF | |||
| FTXH | 42.26 | 0.60 | +1.44% |
| First Trust Nasdaq Pharmaceuticals ETF | |||
| DVAL | 16.62 | 0.11 | +0.65% |
| BrandywineGLOBAL Dyn US Lrg Cap Val ETF | |||
| DTRE | 42.85 | N/A | N/A |
| First Trust Alerian Dsrupt Tech RE ETF | |||
| PYT | 23.47 | -0.20 | -0.84% |
| Merrill Lynch Depositor PPLUS Floating Rate Call TR Cert Ser GSC-2(Goldman Sachs) | |||